Crinetics Pharmaceuticals Inc. (CRNX) NASDAQ
$46.81 2.38 (5.36%)
Market Cap: $3.26B
As of 03/28/24 04:00 PM EDT. Market closed.
Crinetics Pharmaceuticals Inc. (CRNX)
NASDAQ
$46.81
2.38 (5.36%)
Market Cap: $3.26B
As of 03/28/24 04:00 PM EDT. Market closed.
neuropeptide receptor targeted therapeutics for the treatment of endocrine diseases and cancers. we are driven by a passion for drug-hunting and tempered by a post-recession startup culture. our goal is to create new therapeutics that can make a meaningful difference in the lives of our ... read more
neuropeptide receptor targeted therapeutics for the treatment of endocrine diseases and cancers. we are driven by a passion for drug-hunting and tempered by a post-recession startup culture. our goal is to create new therapeutics that can make a meaningful difference in the lives of our patients. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Knight Jeff E. | Chief Operating Officer | Mar 22, 2024 | Option Exercise | $23.98 | 30,000 | 719,400 | 84,939 | Mar 26, 2024, 04:30 PM |
Knight Jeff E. | Chief Operating Officer | Mar 22, 2024 | Sale | $44.31 | 32,359 | 1,433,675 | 54,939 | Mar 26, 2024, 04:30 PM |
Pizzuti Dana | Chief Med and Dev Officer | Mar 20, 2024 | Option Exercise | $16.89 | 14,375 | 242,794 | 38,500 | Mar 22, 2024, 04:52 PM |
Pizzuti Dana | Chief Med and Dev Officer | Mar 20, 2024 | Sale | $44.06 | 15,089 | 664,763 | 28,500 | Mar 22, 2024, 04:52 PM |
Fust Matthew K | Director | Mar 20, 2024 | Option Exercise | $20.92 | 60,000 | 1,254,975 | 36,036 | Mar 22, 2024, 04:31 PM |
Fust Matthew K | Director | Mar 20, 2024 | Sale | $44.14 | 60,000 | 2,648,150 | 18,536 | Mar 22, 2024, 04:31 PM |
Pizzuti Dana | Chief Med and Dev Officer | Mar 18, 2024 | Option Exercise | $38.14 | 411 | 15,676 | 28,500 | Mar 20, 2024, 06:36 PM |
Knight Jeff E. | Chief Operating Officer | Mar 18, 2024 | Option Exercise | $38.14 | 4,283 | 163,354 | 54,939 | Mar 20, 2024, 06:35 PM |
Hassard James | Chief Commercial Officer | Mar 18, 2024 | Option Exercise | $38.14 | 1,741 | 66,402 | 29,259 | Mar 20, 2024, 06:34 PM |
Betz Stephen F. | Chief Scientific Officer | Mar 18, 2024 | Option Exercise | $38.14 | 3,655 | 139,402 | 92,643 | Mar 20, 2024, 06:33 PM |
Wilson Marc | CFO | Mar 18, 2024 | Option Exercise | $38.14 | 3,983 | 151,912 | 117,572 | Mar 20, 2024, 06:32 PM |
Wilson Marc | CFO | Mar 19, 2024 | Sale | $42.91 | 6,942 | 297,881 | 110,630 | Mar 20, 2024, 06:32 PM |
Struthers Richard Scott | President & CEO | Mar 18, 2024 | Option Exercise | $38.14 | 12,687 | 483,882 | 237,835 | Mar 20, 2024, 06:31 PM |
Betz Stephen F. | Chief Scientific Officer | Jan 25, 2024 | Sale | $37.26 | 3,000 | 111,780 | 73,298 | Jan 26, 2024, 05:50 PM |
Betz Stephen F. | Chief Scientific Officer | Jan 10, 2024 | Sale | $37.65 | 3,000 | 112,950 | 76,298 | Jan 12, 2024, 04:12 PM |
Pizzuti Dana | Chief Med and Dev Officer | Jan 03, 2024 | Option Exercise | $16.89 | 14,375 | 242,794 | 20,286 | Jan 04, 2024, 04:45 PM |
Pizzuti Dana | Chief Med and Dev Officer | Jan 03, 2024 | Sale | $35.00 | 14,375 | 503,125 | 5,911 | Jan 04, 2024, 04:45 PM |
Wilson Marc | CFO | Jan 02, 2024 | Option Exercise | $9.28 | 10,000 | 92,800 | 106,055 | Jan 04, 2024, 04:43 PM |
Wilson Marc | CFO | Jan 02, 2024 | Sale | $35.47 | 10,000 | 354,700 | 96,055 | Jan 04, 2024, 04:43 PM |
Betz Stephen F. | Chief Scientific Officer | Dec 26, 2023 | Sale | $35.89 | 3,000 | 107,670 | 79,298 | Dec 27, 2023, 05:20 PM |
Pizzuti Dana | Chief Med and Dev Officer | Dec 21, 2023 | Option Exercise | $16.89 | 9,583 | 161,857 | 15,494 | Dec 22, 2023, 06:45 PM |
Pizzuti Dana | Chief Med and Dev Officer | Dec 21, 2023 | Sale | $34.57 | 9,583 | 331,284 | 5,911 | Dec 22, 2023, 06:45 PM |
Betz Stephen F. | Chief Scientific Officer | Dec 11, 2023 | Sale | $32.87 | 3,000 | 98,610 | 82,298 | Dec 13, 2023, 04:44 PM |
Betz Stephen F. | Chief Scientific Officer | Nov 27, 2023 | Sale | $31.84 | 3,000 | 95,520 | 85,298 | Nov 29, 2023, 04:31 PM |
Struthers Richard Scott | President & CEO | Nov 09, 2023 | Option Exercise | $1.91 | 50,000 | 95,500 | 185,522 | Nov 13, 2023, 04:33 PM |
Struthers Richard Scott | President & CEO | Nov 03, 2023 | Option Exercise | $9.28 | 199,082 | 1,847,481 | 334,604 | Nov 06, 2023, 06:02 PM |
Struthers Richard Scott | President & CEO | Nov 02, 2023 | Option Exercise | $9.28 | 918 | 8,519 | 136,440 | Nov 06, 2023, 06:02 PM |
Struthers Richard Scott | President & CEO | Nov 02, 2023 | Sale | $29.95 | 918 | 27,494 | 135,522 | Nov 06, 2023, 06:02 PM |
Struthers Richard Scott | President & CEO | Nov 03, 2023 | Sale | $30.56 | 199,082 | 6,083,946 | 135,522 | Nov 06, 2023, 06:02 PM |
Wilson Marc | CFO | Nov 01, 2023 | Option Exercise | $9.28 | 10,000 | 92,800 | 105,601 | Nov 03, 2023, 07:38 PM |
Wilson Marc | CFO | Nov 01, 2023 | Sale | $28.75 | 10,000 | 287,500 | 95,601 | Nov 03, 2023, 07:38 PM |
Krasner Alan Seth | Chief Medical Officer | Oct 17, 2023 | Option Exercise | $12.01 | 7,000 | 84,070 | 50,210 | Oct 19, 2023, 05:01 PM |
Krasner Alan Seth | Chief Medical Officer | Oct 17, 2023 | Sale | $30.00 | 7,000 | 210,000 | 43,210 | Oct 19, 2023, 05:01 PM |
Struthers Richard Scott | President & CEO | Aug 14, 2023 | Option Exercise | $1.91 | 10,000 | 19,100 | 135,522 | Aug 16, 2023, 04:30 PM |
Struthers Richard Scott | President & CEO | Jul 13, 2023 | Sale | $20.35 | 14,157 | 288,095 | 630,805 | Jul 13, 2023, 04:56 PM |
Struthers Richard Scott | President & CEO | Jul 12, 2023 | Sale | $20.17 | 11,459 | 231,128 | 644,962 | Jul 13, 2023, 04:56 PM |
Struthers Richard Scott | President & CEO | Jul 11, 2023 | Sale | $20.14 | 24,384 | 491,094 | 656,421 | Jul 13, 2023, 04:56 PM |
Wilson Marc | CFO | Jun 20, 2023 | Option Exercise | $9.28 | 20,000 | 185,600 | 115,158 | Jun 21, 2023, 05:32 PM |
Wilson Marc | CFO | Jun 20, 2023 | Sale | $19.97 | 30,922 | 617,403 | 95,158 | Jun 21, 2023, 05:32 PM |
Struthers Richard Scott | President & CEO | Jun 16, 2023 | Sale | $20.81 | 50,000 | 1,040,500 | 680,805 | Jun 21, 2023, 05:27 PM |
Vivaldi Coelho Rogerio | Director | Jun 08, 2023 | Buy | $22.06 | 5,000 | 110,300 | 5,000 | Jun 09, 2023, 08:00 AM |
Pizzuti Dana | Chief Development Officer | Apr 03, 2023 | Option Exercise | $15.98 | 4,288 | 68,522 | 12,712 | Apr 05, 2023, 07:12 PM |
Pizzuti Dana | Chief Development Officer | Apr 05, 2023 | Sale | $16.15 | 8,212 | 132,624 | 4,500 | Apr 05, 2023, 07:12 PM |
Wilson Marc | CFO | Mar 16, 2023 | Option Exercise | $17.12 | 1,666 | 28,522 | 106,080 | Mar 17, 2023, 05:11 PM |
Struthers Richard Scott | President & CEO | Mar 16, 2023 | Option Exercise | $17.12 | 4,628 | 79,231 | 125,522 | Mar 17, 2023, 05:10 PM |
Krasner Alan Seth | Chief Medical Officer | Mar 16, 2023 | Option Exercise | $17.12 | 1,687 | 28,881 | 42,301 | Mar 17, 2023, 05:09 PM |
Knight Jeff E. | Chief Operating Officer | Mar 16, 2023 | Option Exercise | $17.12 | 587 | 10,049 | 34,400 | Mar 17, 2023, 05:08 PM |
Betz Stephen F. | Chief Scientific Officer | Mar 16, 2023 | Option Exercise | $17.12 | 1,410 | 24,139 | 86,879 | Mar 17, 2023, 05:07 PM |
Betz Stephen F. | Chief Scientific Officer | Feb 01, 2023 | Sale | $19.59 | 3,126 | 61,238 | 64,689 | Feb 03, 2023, 04:30 PM |
Betz Stephen F. | Chief Scientific Officer | Jan 25, 2023 | Sale | $21.07 | 8,336 | 175,640 | 67,815 | Jan 27, 2023, 04:26 PM |
Betz Stephen F. | Chief Scientific Officer | Jan 17, 2023 | Sale | $18.00 | 3,126 | 56,268 | 76,151 | Jan 19, 2023, 04:28 PM |
Betz Stephen F. | Chief Scientific Officer | Jan 03, 2023 | Sale | $18.35 | 3,126 | 57,362 | 79,277 | Jan 05, 2023, 04:23 PM |
Betz Stephen F. | Chief Scientific Officer | Dec 15, 2022 | Sale | $16.00 | 3,126 | 50,016 | 82,403 | Dec 19, 2022, 05:11 PM |
Betz Stephen F. | Chief Scientific Officer | Dec 01, 2022 | Sale | $17.84 | 3,126 | 55,768 | 84,968 | Dec 05, 2022, 05:28 PM |
Betz Stephen F. | Chief Scientific Officer | Nov 15, 2022 | Sale | $18.72 | 3,126 | 58,519 | 88,094 | Nov 17, 2022, 04:46 PM |
Betz Stephen F. | Chief Scientific Officer | Nov 01, 2022 | Sale | $18.52 | 3,126 | 57,894 | 91,220 | Nov 03, 2022, 04:35 PM |
Betz Stephen F. | Chief Scientific Officer | Oct 17, 2022 | Sale | $17.73 | 3,126 | 55,424 | 94,346 | Oct 19, 2022, 05:34 PM |
Struthers Richard Scott | President & CEO | Oct 12, 2022 | Option Exercise | $1.91 | 11,100 | 21,201 | 68,500 | Oct 14, 2022, 04:55 PM |
Betz Stephen F. | Chief Scientific Officer | Oct 03, 2022 | Sale | $19.64 | 3,126 | 61,395 | 97,472 | Oct 05, 2022, 04:40 PM |
Betz Stephen F. | Chief Scientific Officer | Sep 15, 2022 | Sale | $21.01 | 4,168 | 87,570 | 100,598 | Sep 19, 2022, 04:40 PM |
Betz Stephen F. | Chief Scientific Officer | Sep 07, 2022 | Sale | $21.00 | 1,042 | 21,884 | 104,766 | Sep 09, 2022, 04:20 PM |
Betz Stephen F. | Chief Scientific Officer | May 20, 2022 | Option Exercise | $11.02 | 1,336 | 14,723 | 108,934 | Sep 06, 2022, 04:20 PM |
Betz Stephen F. | Chief Scientific Officer | Sep 01, 2022 | Sale | $18.59 | 3,126 | 58,112 | 105,808 | Sep 06, 2022, 04:20 PM |
Knight Jeff E. | Chief Operating Officer | May 20, 2022 | Option Exercise | $17.44 | 1,152 | 20,091 | 6,102 | Jul 29, 2022, 04:26 PM |
Knight Jeff E. | Chief Operating Officer | Jul 26, 2022 | Sale | $20.70 | 1,152 | 23,847 | 4,950 | Jul 29, 2022, 04:26 PM |
Fust Matthew K | Director | Jul 13, 2022 | Option Exercise | $1.45 | 5,700 | 8,265 | 18,236 | Jul 15, 2022, 04:30 PM |
Fust Matthew K | Director | Jul 13, 2022 | Sale | $20.96 | 5,700 | 119,455 | 12,536 | Jul 15, 2022, 04:30 PM |
Betz Stephen F. | Chief Scientific Officer | May 02, 2022 | Sale | $20.10 | 3,247 | 65,252 | 107,598 | May 04, 2022, 05:01 PM |
Betz Stephen F. | Chief Scientific Officer | Apr 18, 2022 | Sale | $25.81 | 5,664 | 146,188 | 110,845 | Apr 21, 2022, 05:00 PM |
PERCEPTIVE ADVISORS LLC | 10% Owner | Apr 18, 2022 | Buy | $22.22 | 157,515 | 3,499,983 | 5,321,032 | Apr 18, 2022, 05:39 PM |
Struthers Richard Scott | President & CEO | Apr 13, 2022 | Sale | $26.83 | 138,643 | 3,719,625 | 844,774 | Apr 15, 2022, 06:00 PM |
Struthers Richard Scott | President & CEO | Apr 05, 2022 | Sale | $25.34 | 21,357 | 541,225 | 869,448 | Apr 07, 2022, 05:58 PM |
Betz Stephen F. | Chief Scientific Officer | Apr 04, 2022 | Sale | $23.97 | 9,000 | 215,761 | 116,509 | Apr 06, 2022, 07:08 PM |
Betz Stephen F. | Chief Scientific Officer | Apr 01, 2022 | Sale | $21.80 | 4,164 | 90,775 | 125,509 | Apr 01, 2022, 05:39 PM |
Betz Stephen F. | Chief Scientific Officer | Mar 31, 2022 | Sale | $21.06 | 4,164 | 87,700 | 129,673 | Apr 01, 2022, 05:39 PM |
Betz Stephen F. | Chief Scientific Officer | Mar 15, 2022 | Sale | $18.94 | 3,123 | 59,150 | 133,837 | Mar 17, 2022, 04:33 PM |
Madan Ajay | Chief Development Officer | Mar 01, 2022 | Sale | $19.88 | 9,000 | 178,920 | 176,995 | Mar 02, 2022, 09:00 PM |
Betz Stephen F. | Chief Scientific Officer | Mar 01, 2022 | Sale | $19.73 | 3,123 | 61,617 | 136,960 | Mar 02, 2022, 09:00 PM |
Betz Stephen F. | Chief Scientific Officer | Feb 15, 2022 | Sale | $18.64 | 3,123 | 58,213 | 123,583 | Feb 17, 2022, 04:34 PM |
Madan Ajay | Chief Development Officer | Feb 07, 2022 | Sale | $17.83 | 13,411 | 239,085 | 172,045 | Feb 09, 2022, 05:00 PM |
Betz Stephen F. | Chief Scientific Officer | Feb 01, 2022 | Sale | $18.79 | 3,123 | 58,681 | 126,706 | Feb 03, 2022, 04:30 PM |
Krasner Alan Seth | Chief Medical Officer | Jan 19, 2022 | Option Exercise | $12.01 | 6,700 | 80,467 | 15,011 | Jan 21, 2022, 04:54 PM |
Krasner Alan Seth | Chief Medical Officer | Jan 19, 2022 | Sale | $21.21 | 6,700 | 142,080 | 8,311 | Jan 21, 2022, 04:54 PM |
Betz Stephen F. | Chief Scientific Officer | Jan 18, 2022 | Sale | $23.29 | 4,168 | 97,073 | 128,875 | Jan 20, 2022, 04:47 PM |
Betz Stephen F. | Chief Scientific Officer | Jan 03, 2022 | Sale | $28.02 | 7,168 | 200,847 | 133,043 | Jan 06, 2022, 04:37 PM |
Betz Stephen F. | Chief Scientific Officer | Dec 28, 2021 | Sale | $27.95 | 3,000 | 83,852 | 140,211 | Dec 30, 2021, 07:19 PM |
Betz Stephen F. | Chief Scientific Officer | Dec 15, 2021 | Sale | $24.14 | 5,668 | 136,826 | 143,211 | Dec 17, 2021, 04:28 PM |
Betz Stephen F. | Chief Scientific Officer | Dec 01, 2021 | Sale | $27.38 | 5,668 | 155,190 | 148,879 | Dec 03, 2021, 04:36 PM |
Betz Stephen F. | Chief Scientific Officer | Nov 16, 2021 | Sale | $27.97 | 1,500 | 41,955 | 154,547 | Nov 17, 2021, 05:01 PM |
Betz Stephen F. | Chief Scientific Officer | Nov 15, 2021 | Sale | $26.75 | 5,668 | 151,619 | 156,047 | Nov 17, 2021, 05:01 PM |
Betz Stephen F. | Chief Scientific Officer | Nov 08, 2021 | Sale | $28.42 | 3,900 | 110,846 | 161,715 | Nov 09, 2021, 05:44 PM |
Betz Stephen F. | Chief Scientific Officer | Nov 05, 2021 | Sale | $27.95 | 12,600 | 352,195 | 165,615 | Nov 09, 2021, 05:44 PM |
Betz Stephen F. | Chief Scientific Officer | Nov 01, 2021 | Sale | $24.79 | 5,668 | 140,510 | 178,215 | Nov 03, 2021, 04:57 PM |
Fust Matthew K | Director | Nov 01, 2021 | Option Exercise | $1.91 | 8,954 | 17,102 | 21,490 | Nov 03, 2021, 04:55 PM |
Fust Matthew K | Director | Nov 01, 2021 | Sale | $25.50 | 8,954 | 228,327 | 12,536 | Nov 03, 2021, 04:55 PM |
Madan Ajay | Chief Development Officer | Oct 28, 2021 | Option Exercise | $0.73 | 106,383 | 77,660 | 184,671 | Nov 01, 2021, 07:11 PM |
Betz Stephen F. | Chief Scientific Officer | Oct 27, 2021 | Sale | $24.00 | 3,000 | 71,991 | 183,883 | Oct 28, 2021, 05:00 PM |
Betz Stephen F. | Chief Scientific Officer | Oct 21, 2021 | Sale | $21.10 | 1,042 | 21,984 | 186,883 | Oct 25, 2021, 04:28 PM |
PERCEPTIVE ADVISORS LLC | 10% Owner | Oct 25, 2021 | Buy | $19.80 | 1,200,000 | 23,759,999 | 5,163,517 | Oct 25, 2021, 02:47 PM |
Fust Matthew K | Director | Sep 08, 2021 | Option Exercise | $1.91 | 6,046 | 11,548 | 18,582 | Sep 09, 2021, 05:00 PM |
Fust Matthew K | Director | Sep 08, 2021 | Sale | $25.50 | 6,046 | 154,173 | 12,536 | Sep 09, 2021, 05:00 PM |
Struthers Richard Scott | President & CEO | Sep 07, 2021 | Sale | $25.00 | 10,000 | 250,000 | 90,000 | Sep 09, 2021, 05:00 PM |
Struthers Richard Scott | President & CEO | Sep 07, 2021 | Sale | $25.00 | 10,000 | 250,000 | 90,000 | Sep 09, 2021, 05:00 PM |
Struthers Richard Scott | President & CEO | Sep 07, 2021 | Sale | $25.00 | 10,000 | 250,000 | 90,000 | Sep 09, 2021, 05:00 PM |
Fust Matthew K | Director | Jul 26, 2021 | Option Exercise | $1.91 | 5,000 | 9,550 | 17,536 | Jul 27, 2021, 08:00 PM |
Fust Matthew K | Director | Jul 26, 2021 | Sale | $19.59 | 5,000 | 97,950 | 12,536 | Jul 27, 2021, 08:00 PM |
Fust Matthew K | Director | Jul 19, 2021 | Option Exercise | $1.91 | 5,000 | 9,550 | 17,536 | Jul 20, 2021, 05:00 PM |
Fust Matthew K | Director | Jul 19, 2021 | Sale | $19.50 | 5,000 | 97,500 | 12,536 | Jul 20, 2021, 05:00 PM |
Fust Matthew K | Director | Jul 12, 2021 | Option Exercise | $1.91 | 5,000 | 9,550 | 17,536 | Jul 13, 2021, 05:00 PM |
Fust Matthew K | Director | Jul 12, 2021 | Sale | $20.71 | 5,000 | 103,550 | 12,536 | Jul 13, 2021, 05:00 PM |
PERCEPTIVE ADVISORS LLC | 10% Owner | Apr 08, 2021 | Buy | $16.44 | 304,136 | 4,999,996 | 3,963,517 | Apr 09, 2021, 09:00 AM |
Struthers Richard Scott | President & CEO | Dec 03, 2020 | Buy | $13.10 | 4,000 | 52,400 | 4,000 | Dec 04, 2020, 04:59 PM |
Struthers Richard Scott | President & CEO | Dec 02, 2020 | Buy | $12.60 | 1,000 | 12,600 | 1,000 | Dec 04, 2020, 04:59 PM |
Struthers Richard Scott | President & CEO | Jul 16, 2020 | Sale | $14.46 | 17,500 | 253,108 | 890,805 | Jul 17, 2020, 05:05 PM |
Struthers Richard Scott | President & CEO | Jul 15, 2020 | Sale | $15.30 | 17,500 | 267,722 | 908,305 | Jul 17, 2020, 05:05 PM |
WIERENGA WENDALL | Director | Apr 28, 2020 | Option Exercise | $0.73 | 25,329 | 18,490 | 99,846 | Apr 29, 2020, 05:01 PM |
PERCEPTIVE ADVISORS LLC | 10% Owner | Apr 17, 2020 | Buy | $14.00 | 1,071,428 | 14,999,992 | 3,659,381 | Apr 20, 2020, 08:30 AM |
Vivo Capital VIII, LLC | 10% Owner | Apr 17, 2020 | Sale | $15.40 | 84,598 | 1,302,809 | 2,162,587 | Apr 17, 2020, 06:38 PM |
Vivo Capital VIII, LLC | 10% Owner | Apr 16, 2020 | Sale | $15.20 | 30,190 | 458,888 | 2,236,920 | Apr 17, 2020, 06:38 PM |
Vivo Capital VIII, LLC | 10% Owner | Apr 15, 2020 | Sale | $15.50 | 215,810 | 3,345,055 | 2,263,447 | Apr 17, 2020, 06:38 PM |
Vivo Capital VIII, LLC | 10% Owner | Apr 07, 2020 | Sale | $14.20 | 6,115 | 86,833 | 2,453,072 | Apr 07, 2020, 07:27 PM |
Vivo Capital VIII, LLC | 10% Owner | Apr 03, 2020 | Sale | $13.80 | 300,000 | 4,140,000 | 2,458,445 | Apr 07, 2020, 07:27 PM |
Vivo Capital VIII, LLC | 10% Owner | Mar 09, 2020 | Sale | $19.50 | 528 | 10,296 | 2,722,045 | Mar 11, 2020, 05:12 PM |
Vivo Capital VIII, LLC | 10% Owner | Feb 10, 2020 | Sale | $21.40 | 7,555 | 161,677 | 2,722,392 | Feb 11, 2020, 08:00 PM |
Vivo Capital VIII, LLC | 10% Owner | Feb 07, 2020 | Sale | $22.00 | 5,905 | 129,910 | 2,723,843 | Feb 11, 2020, 08:00 PM |
Vivo Capital VIII, LLC | 10% Owner | Feb 04, 2020 | Sale | $22.80 | 13,460 | 306,888 | 2,724,977 | Feb 06, 2020, 07:22 PM |
Vivo Capital VIII, LLC | 10% Owner | Jan 31, 2020 | Sale | $21.70 | 5,400 | 117,180 | 2,727,561 | Jan 31, 2020, 08:00 PM |
Vivo Capital VIII, LLC | 10% Owner | Jan 30, 2020 | Sale | $22.10 | 7,600 | 167,960 | 2,728,598 | Jan 31, 2020, 08:00 PM |
Vivo Capital VIII, LLC | 10% Owner | Jan 29, 2020 | Sale | $22.20 | 13,920 | 309,024 | 2,730,057 | Jan 31, 2020, 08:00 PM |
Fust Matthew K | Director | Dec 16, 2019 | Option Exercise | $1.91 | 3,500 | 6,685 | 16,036 | Dec 18, 2019, 06:32 PM |
Fust Matthew K | Director | Dec 16, 2019 | Sale | $22.50 | 3,500 | 78,750 | 12,536 | Dec 18, 2019, 06:32 PM |
Struthers Richard Scott | President & CEO | Aug 05, 2019 | Option Exercise | $1.91 | 10,000 | 19,100 | 1,225,805 | Aug 07, 2019, 07:31 PM |
5AM Ventures IV, L.P. | Former 10% holder | Jun 21, 2019 | Sale | $22.20 | 250,000 | 5,550,000 | 2,267,797 | Jun 25, 2019, 07:03 PM |
Vivo Capital VIII, LLC | 10% Owner | Mar 20, 2019 | Sale | $22.25 | 417,000 | 9,278,250 | 2,732,730 | Mar 25, 2019, 06:04 AM |
5AM Ventures IV, L.P. | 10% Owner | Mar 18, 2019 | Sale | $24.25 | 154,839 | 3,754,954 | 2,507,797 | Mar 20, 2019, 04:48 PM |
5AM Ventures IV, L.P. | 10% Owner | Jan 22, 2019 | Sale | $21.88 | 262,153 | 5,734,597 | 3,107,642 | Jan 24, 2019, 07:01 PM |
PERCEPTIVE ADVISORS LLC | Director | Jul 20, 2018 | Buy | $17.00 | 400,000 | 6,800,000 | 2,587,953 | Aug 27, 2018, 06:12 PM |
PERCEPTIVE ADVISORS LLC | Director | Jul 18, 2018 | Buy | $21.30 | 307,648 | 6,552,902 | 307,648 | Aug 27, 2018, 06:12 PM |
5AM Ventures IV, L.P. | 10% Owner | Jul 20, 2018 | Buy | $17.00 | 115,000 | 1,955,000 | 3,359,309 | Jul 20, 2018, 07:02 PM |
PERCEPTIVE ADVISORS LLC | Director | Jul 20, 2018 | Buy | $17.00 | 400,000 | 6,800,000 | 2,280,305 | Jul 20, 2018, 05:19 PM |
Vivo Capital VIII, LLC | 10% Owner | Jul 20, 2018 | Buy | $18.62 | 353,180 | 6,575,421 | 3,025,339 | Jul 20, 2018, 04:50 PM |
Krasner Alan Seth | Chief Medical Officer | Jul 20, 2018 | Buy | $17.00 | 2,000 | 34,000 | 2,000 | Jul 20, 2018, 04:06 PM |
Owner | Relationship | Date | Value($) |
Knight Jeff E. | Chief Operating Officer | 03/22/2024 | 719,400 |
Knight Jeff E. | Chief Operating Officer | 03/22/2024 | 1,433,675 |
Pizzuti Dana | Chief Med and Dev Officer | 03/20/2024 | 242,794 |
Pizzuti Dana | Chief Med and Dev Officer | 03/20/2024 | 664,763 |
Fust Matthew K | Director | 03/20/2024 | 1,254,975 |
Fust Matthew K | Director | 03/20/2024 | 2,648,150 |
Pizzuti Dana | Chief Med and Dev Officer | 03/18/2024 | 15,676 |
Knight Jeff E. | Chief Operating Officer | 03/18/2024 | 163,354 |
Hassard James | Chief Commercial Officer | 03/18/2024 | 66,402 |
Betz Stephen F. | Chief Scientific Officer | 03/18/2024 | 139,402 |
Wilson Marc | CFO | 03/18/2024 | 151,912 |
Wilson Marc | CFO | 03/19/2024 | 297,881 |
Struthers Richard Scott | President & CEO | 03/18/2024 | 483,882 |
Betz Stephen F. | Chief Scientific Officer | 01/25/2024 | 111,780 |
Betz Stephen F. | Chief Scientific Officer | 01/10/2024 | 112,950 |
Pizzuti Dana | Chief Med and Dev Officer | 01/03/2024 | 242,794 |
Pizzuti Dana | Chief Med and Dev Officer | 01/03/2024 | 503,125 |
Wilson Marc | CFO | 01/02/2024 | 92,800 |
Wilson Marc | CFO | 01/02/2024 | 354,700 |
Betz Stephen F. | Chief Scientific Officer | 12/26/2023 | 107,670 |
Pizzuti Dana | Chief Med and Dev Officer | 12/21/2023 | 161,857 |
Pizzuti Dana | Chief Med and Dev Officer | 12/21/2023 | 331,284 |
Betz Stephen F. | Chief Scientific Officer | 12/11/2023 | 98,610 |
Betz Stephen F. | Chief Scientific Officer | 11/27/2023 | 95,520 |
Struthers Richard Scott | President & CEO | 11/09/2023 | 95,500 |
Struthers Richard Scott | President & CEO | 11/03/2023 | 1,847,481 |
Struthers Richard Scott | President & CEO | 11/02/2023 | 8,519 |
Struthers Richard Scott | President & CEO | 11/02/2023 | 27,494 |
Struthers Richard Scott | President & CEO | 11/03/2023 | 6,083,946 |
Wilson Marc | CFO | 11/01/2023 | 92,800 |
Wilson Marc | CFO | 11/01/2023 | 287,500 |
Krasner Alan Seth | Chief Medical Officer | 10/17/2023 | 84,070 |
Krasner Alan Seth | Chief Medical Officer | 10/17/2023 | 210,000 |
Struthers Richard Scott | President & CEO | 08/14/2023 | 19,100 |
Struthers Richard Scott | President & CEO | 07/13/2023 | 288,095 |
Struthers Richard Scott | President & CEO | 07/12/2023 | 231,128 |
Struthers Richard Scott | President & CEO | 07/11/2023 | 491,094 |
Wilson Marc | CFO | 06/20/2023 | 185,600 |
Wilson Marc | CFO | 06/20/2023 | 617,403 |
Struthers Richard Scott | President & CEO | 06/16/2023 | 1,040,500 |
Vivaldi Coelho Rogerio | Director | 06/08/2023 | 110,300 |
Pizzuti Dana | Chief Development Officer | 04/03/2023 | 68,522 |
Pizzuti Dana | Chief Development Officer | 04/05/2023 | 132,624 |
Wilson Marc | CFO | 03/16/2023 | 28,522 |
Struthers Richard Scott | President & CEO | 03/16/2023 | 79,231 |
Krasner Alan Seth | Chief Medical Officer | 03/16/2023 | 28,881 |
Knight Jeff E. | Chief Operating Officer | 03/16/2023 | 10,049 |
Betz Stephen F. | Chief Scientific Officer | 03/16/2023 | 24,139 |
Betz Stephen F. | Chief Scientific Officer | 02/01/2023 | 61,238 |
Betz Stephen F. | Chief Scientific Officer | 01/25/2023 | 175,640 |
Betz Stephen F. | Chief Scientific Officer | 01/17/2023 | 56,268 |
Betz Stephen F. | Chief Scientific Officer | 01/03/2023 | 57,362 |
Betz Stephen F. | Chief Scientific Officer | 12/15/2022 | 50,016 |
Betz Stephen F. | Chief Scientific Officer | 12/01/2022 | 55,768 |
Betz Stephen F. | Chief Scientific Officer | 11/15/2022 | 58,519 |
Betz Stephen F. | Chief Scientific Officer | 11/01/2022 | 57,894 |
Betz Stephen F. | Chief Scientific Officer | 10/17/2022 | 55,424 |
Struthers Richard Scott | President & CEO | 10/12/2022 | 21,201 |
Betz Stephen F. | Chief Scientific Officer | 10/03/2022 | 61,395 |
Betz Stephen F. | Chief Scientific Officer | 09/15/2022 | 87,570 |
Betz Stephen F. | Chief Scientific Officer | 09/07/2022 | 21,884 |
Betz Stephen F. | Chief Scientific Officer | 05/20/2022 | 14,723 |
Betz Stephen F. | Chief Scientific Officer | 09/01/2022 | 58,112 |
Knight Jeff E. | Chief Operating Officer | 05/20/2022 | 20,091 |
Knight Jeff E. | Chief Operating Officer | 07/26/2022 | 23,847 |
Fust Matthew K | Director | 07/13/2022 | 8,265 |
Fust Matthew K | Director | 07/13/2022 | 119,455 |
Betz Stephen F. | Chief Scientific Officer | 05/02/2022 | 65,252 |
Betz Stephen F. | Chief Scientific Officer | 04/18/2022 | 146,188 |
PERCEPTIVE ADVISORS LLC | 10% Owner | 04/18/2022 | 3,499,983 |
Struthers Richard Scott | President & CEO | 04/13/2022 | 3,719,625 |
Struthers Richard Scott | President & CEO | 04/05/2022 | 541,225 |
Betz Stephen F. | Chief Scientific Officer | 04/04/2022 | 215,761 |
Betz Stephen F. | Chief Scientific Officer | 04/01/2022 | 90,775 |
Betz Stephen F. | Chief Scientific Officer | 03/31/2022 | 87,700 |
Betz Stephen F. | Chief Scientific Officer | 03/15/2022 | 59,150 |
Madan Ajay | Chief Development Officer | 03/01/2022 | 178,920 |
Betz Stephen F. | Chief Scientific Officer | 03/01/2022 | 61,617 |
Betz Stephen F. | Chief Scientific Officer | 02/15/2022 | 58,213 |
Madan Ajay | Chief Development Officer | 02/07/2022 | 239,085 |
Betz Stephen F. | Chief Scientific Officer | 02/01/2022 | 58,681 |
Krasner Alan Seth | Chief Medical Officer | 01/19/2022 | 80,467 |
Krasner Alan Seth | Chief Medical Officer | 01/19/2022 | 142,080 |
Betz Stephen F. | Chief Scientific Officer | 01/18/2022 | 97,073 |
Betz Stephen F. | Chief Scientific Officer | 01/03/2022 | 200,847 |
Betz Stephen F. | Chief Scientific Officer | 12/28/2021 | 83,852 |
Betz Stephen F. | Chief Scientific Officer | 12/15/2021 | 136,826 |
Betz Stephen F. | Chief Scientific Officer | 12/01/2021 | 155,190 |
Betz Stephen F. | Chief Scientific Officer | 11/16/2021 | 41,955 |
Betz Stephen F. | Chief Scientific Officer | 11/15/2021 | 151,619 |
Betz Stephen F. | Chief Scientific Officer | 11/08/2021 | 110,846 |
Betz Stephen F. | Chief Scientific Officer | 11/05/2021 | 352,195 |
Betz Stephen F. | Chief Scientific Officer | 11/01/2021 | 140,510 |
Fust Matthew K | Director | 11/01/2021 | 17,102 |
Fust Matthew K | Director | 11/01/2021 | 228,327 |
Madan Ajay | Chief Development Officer | 10/28/2021 | 77,660 |
Betz Stephen F. | Chief Scientific Officer | 10/27/2021 | 71,991 |
Betz Stephen F. | Chief Scientific Officer | 10/21/2021 | 21,984 |
PERCEPTIVE ADVISORS LLC | 10% Owner | 10/25/2021 | 23,759,999 |
Fust Matthew K | Director | 09/08/2021 | 11,548 |
Fust Matthew K | Director | 09/08/2021 | 154,173 |
Struthers Richard Scott | President & CEO | 09/07/2021 | 250,000 |
Struthers Richard Scott | President & CEO | 09/07/2021 | 250,000 |
Struthers Richard Scott | President & CEO | 09/07/2021 | 250,000 |
Fust Matthew K | Director | 07/26/2021 | 9,550 |
Fust Matthew K | Director | 07/26/2021 | 97,950 |
Fust Matthew K | Director | 07/19/2021 | 9,550 |
Fust Matthew K | Director | 07/19/2021 | 97,500 |
Fust Matthew K | Director | 07/12/2021 | 9,550 |
Fust Matthew K | Director | 07/12/2021 | 103,550 |
PERCEPTIVE ADVISORS LLC | 10% Owner | 04/08/2021 | 4,999,996 |
Struthers Richard Scott | President & CEO | 12/03/2020 | 52,400 |
Struthers Richard Scott | President & CEO | 12/02/2020 | 12,600 |
Struthers Richard Scott | President & CEO | 07/16/2020 | 253,108 |
Struthers Richard Scott | President & CEO | 07/15/2020 | 267,722 |
WIERENGA WENDALL | Director | 04/28/2020 | 18,490 |
PERCEPTIVE ADVISORS LLC | 10% Owner | 04/17/2020 | 14,999,992 |
Vivo Capital VIII, LLC | 10% Owner | 04/17/2020 | 1,302,809 |
Vivo Capital VIII, LLC | 10% Owner | 04/16/2020 | 458,888 |
Vivo Capital VIII, LLC | 10% Owner | 04/15/2020 | 3,345,055 |
Vivo Capital VIII, LLC | 10% Owner | 04/07/2020 | 86,833 |
Vivo Capital VIII, LLC | 10% Owner | 04/03/2020 | 4,140,000 |
Vivo Capital VIII, LLC | 10% Owner | 03/09/2020 | 10,296 |
Vivo Capital VIII, LLC | 10% Owner | 02/10/2020 | 161,677 |
Vivo Capital VIII, LLC | 10% Owner | 02/07/2020 | 129,910 |
Vivo Capital VIII, LLC | 10% Owner | 02/04/2020 | 306,888 |
Vivo Capital VIII, LLC | 10% Owner | 01/31/2020 | 117,180 |
Vivo Capital VIII, LLC | 10% Owner | 01/30/2020 | 167,960 |
Vivo Capital VIII, LLC | 10% Owner | 01/29/2020 | 309,024 |
Fust Matthew K | Director | 12/16/2019 | 6,685 |
Fust Matthew K | Director | 12/16/2019 | 78,750 |
Struthers Richard Scott | President & CEO | 08/05/2019 | 19,100 |
5AM Ventures IV, L.P. | Former 10% holder | 06/21/2019 | 5,550,000 |
Vivo Capital VIII, LLC | 10% Owner | 03/20/2019 | 9,278,250 |
5AM Ventures IV, L.P. | 10% Owner | 03/18/2019 | 3,754,954 |
5AM Ventures IV, L.P. | 10% Owner | 01/22/2019 | 5,734,597 |
PERCEPTIVE ADVISORS LLC | Director | 07/20/2018 | 6,800,000 |
PERCEPTIVE ADVISORS LLC | Director | 07/18/2018 | 6,552,902 |
5AM Ventures IV, L.P. | 10% Owner | 07/20/2018 | 1,955,000 |
PERCEPTIVE ADVISORS LLC | Director | 07/20/2018 | 6,800,000 |
Vivo Capital VIII, LLC | 10% Owner | 07/20/2018 | 6,575,421 |
Krasner Alan Seth | Chief Medical Officer | 07/20/2018 | 34,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 5,345,114 | 0.00485% | 10.31% | Other |
DRIEHAUS CAPITAL MANAGEMENT LLC | 5,039,957 | 2.16% | -1.8% | Growth |
ORBIMED ADVISORS LLC | 1,667,360 | 1.18% | -42.43% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 1,352,672 | 0.00504% | 6.54% | Other |
FISHER ASSET MANAGEMENT, LLC | 441,295 | 0.0083% | 719.34% | Other |
FARALLON CAPITAL MANAGEMENT LLC | 122,904 | 0.02% | -66.04% | Event Driven, Value |
VIVO CAPITAL, LLC | 350,000 | 1.02% | No change | Other |
CANDRIAM S.C.A. | 288,011 | 0.07% | New | Other |
RENAISSANCE TECHNOLOGIES LLC | 11,700 | 0.00064% | -92.85% | Other |
UBS OCONNOR LLC | 30,000 (Call) | 0.00485% | -50% | Value |
D. E. SHAW & CO., INC. | 17,005 | 0.00053% | -63.39% | Other |
ALPS ADVISORS INC | 46,025 | 0.01% | 14.13% | Other |
TUDOR INVESTMENT CORP ET AL | 39,764 | 0.01% | 20.5% | Event Driven, Other |
UBS OCONNOR LLC | 35,000 (Put) | 0.00002% | Exited | Value |
UBS OCONNOR LLC | 10,038 | 0.03% | -61.62% | Value |
AQR CAPITAL MANAGEMENT LLC | 6,686 | 0.00045% | New | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View